Urology Today.net

Site updated at Thursday, 28 January 2016

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



primary hematuria1 - nuclear scintigraphy4 - abdominal radiograph1 - myocardial infarction1 - iliococcygeus1 - external sphincter dyssynergia1 - psa tests1 - gum disease1 - onset1 - adpkd3 - high-precision surgical robot1 - genetic disease1 - pelvic irradiation1 - proteins ralb1 - urinary tract problems1 - urinary proteins2 - ectopic pregnancy2 - low-calorie diet1 - prognostic tests1 - vitamin d1 - journal of urology5 - pioglitazone1 - medullary cystic disease1 - low carbohydrate diet1 - methoxyflurane1 - pelvic inflammatory disease2 - pluripotent stem cells1 - proton therapy1 - hepatolenticular degeneration1 - female incontinence1 -